A Unique Case of Heat-Induced Livedo Reticularis Following Initiation of Upadacitinib
SKIN The Journal of Cutaneous Medicine · 10.03.2026 · 10 (2) · 3040-3042
DOI: 10.25251/wy630049 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.03.2026. Verfasst von Anya Patel und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Livedo reticularis is a benign condition characterized by a mottled appearance of the skin that is most frequently triggered by exposure to cold temperatures. It is painless and often self-resolves after trigger avoidance. Upadacitinib is a Janus kinase inhibitor approved for the treatment of several inflammatory and autoimmune diseases including atopic dermatitis and psoriatic arthritis. Here, we report a case of heat-induced livedo reticularis following initiation of treatment with upadacitinib for an ixekizumab-triggered paradoxical eczematous flare. This presentation expands the spectrum of cutaneous vascular changes potentially associated with JAK-inhibitors and underscores the importance of clinician awareness to support counseling, avoid unnecessary workup, and guide ongoing monitoring.
Zitieren
APA
Patel, A., Karpoff, K., & Lebwohl, M. (2026). A Unique Case of Heat-Induced Livedo Reticularis Following Initiation of Upadacitinib. SKIN The Journal of Cutaneous Medicine, 10(2), 3040-3042. https://doi.org/10.25251/wy630049
Vancouver
Patel A, Karpoff K, Lebwohl M. A Unique Case of Heat-Induced Livedo Reticularis Following Initiation of Upadacitinib. SKIN The Journal of Cutaneous Medicine. 2026;10(2):3040-3042. doi:10.25251/wy630049
BibTeX
@article{Patel2026,
author = {Patel, Anya and Karpoff, Kateryna and Lebwohl, Mark},
title = {A Unique Case of Heat-Induced Livedo Reticularis Following Initiation of Upadacitinib},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {2},
pages = {3040--3042},
doi = {10.25251/wy630049}
}
EUVIMED